Mark Soave

Mark Soave has work experience as a Senior Scientist at OMass Therapeutics since September 2021. Prior to this role, they worked as a Postdoctoral Research Fellow at The University of Nottingham from November 2016 to September 2021. Mark also had a temporary role as a Research Assistant at Novozymes from March 2013 to September 2013.

Mark Soave has a strong educational background in the field of science. Mark earned their Doctor of Philosophy (PhD) degree in Molecular Pharmacology from the University of Nottingham, where they attended from 2013 to 2017. Prior to that, Mark completed a Master's degree (MRes) in Biomedical Research at Imperial College London, studying there from 2011 to 2012. In 2011, they obtained their Bachelor of Science (BSc Hons) degree in Cell Biology from Durham University.